INVESTMENT SECURITIES, RELATED PARY (Details) - USD ($)	Mar. 31, 2022	Sep. 30, 2021
Prepaid Expenses	$ 34,582	$ 48,144
Accrued Interest Receivable	496	230
Accounts Payable	41,629	$ 91,498
Series M Preferred Stock [Member] | Zander Therapeutics
Fair Value of Intellectual Property	1,500
Prepaid Expenses	74,298
Due from Employee	1,071
Note Receivable	64,400
Accrued Interest Receivable	20,274
Investment Securities	593,357
Convertible Note Receivable	10,000
Accounts Payable	1,269,041
Notes Payable	500,000
Accrued Expenses, Related Party	89,529
Accrued Expenses	203,037
Enterprise Value	2,826,507
Less: Total Debt	2,061,607
Portion of Enterprise Value attributable to Shareholders	$ 764,900
Fair Value per share	$ 0.0167
Common Stock [Member] | Zander Therapeutics
Fair Value of Intellectual Property	$ 1,500
Prepaid Expenses	74,298
Due from Employee	1,071
Note Receivable	64,400
Accrued Interest Receivable	20,274
Investment Securities	593,357
Convertible Note Receivable	10,000
Accounts Payable	1,269,041
Notes Payable	500,000
Accrued Expenses, Related Party	89,529
Accrued Expenses	203,037
Enterprise Value	2,826,507
Less: Total Debt	2,061,607
Portion of Enterprise Value attributable to Shareholders	$ 764,900
Fair Value per share	$ 0.0167